-
Mashup Score: 6
The role of venous congestion in abnormal kidney function is being increasingly recognized. It is well known that unresolved congestion is associated with adverse kidney and overall outcomes in patients with heart failure. Similarly, any condition that leads to elevated central venous pressure, such as pulmonary hypertension, can result in impaired kidney perfusion by increasing its afterload….
Source: Kidney MedicineCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 22CKD-Associated Cardiovascular Mortality in the United States: Temporal Trends From 1999 to 2020 - 1 year(s) ago
Chronic kidney disease (CKD) is associated with an increased risk of cardiovascular (CV) mortality, but there are limited data on temporal trends disaggregated by sex, race, and urban/rural status in this population.
Source: Kidney MedicineCategories: Cardiologists, Latest HeadlinesTweet-
RT @mmamas1973: 1. Our analysis led by @KoboOfer and @DmitryAbramovMD around CKD associated mortality ā”ļø https://t.co/IDFGI4F1hH Between 1ā¦
-
-
Mashup Score: 24CKD-Associated Cardiovascular Mortality in the United States: Temporal Trends From 1999 to 2020 - 1 year(s) ago
Chronic kidney disease (CKD) is associated with an increased risk of cardiovascular (CV) mortality, but there are limited data on temporal trends disaggregated by sex, race, and urban/rural status in this population.
Source: Kidney MedicineCategories: Cardiologists, Latest HeadlinesTweet-
1. Our analysis led by @KoboOfer and @DmitryAbramovMD around CKD associated mortality ā”ļø https://t.co/IDFGI4F1hH Between 1999 - 2020, 1,938,505 death certificates with CK. non CV mortality ā¬ļø 86.6% , CV mortality ā¬ļø 7.1% with @hvanspall @SofiaAhmedMD @purviparwani @DrJMieresā¦ https://t.co/6oVH5Uwq45 https://t.co/9dE84y6oDw
-
-
Mashup Score: 7
Dietary sodium restriction is commonly recommended to ambulatory patients with heart failure by clinicians worldwide, in the hope of preventing volume overload and improving excess cardiovascular mortality. However, the evidence base for this practice is limited, with a recent meta-analysis demonstrating heterogeneity and highlighting the small sample sizes in individual randomized controlled…
Source: Kidney MedicineCategories: Latest Headlines, NephrologyTweet-
RT @KidneyMed: Remove the āStrictā From āRestrictionā: A #NephJC Editorial on SODIUM-HF @NephJC @NSMCInternship https://t.co/uD38mjmdaVā¦
-
-
Mashup Score: 1Nephrology Fellow Boot Camp Training: A Single Center Experience - 1 year(s) ago
Nephrology is an exciting and dynamic field of study, though its complexity can be daunting for new trainees. The complexity of nephrology patients and topics and perceived poor work-life balance are cited as reasons medical trainees have excluded nephrology as a career option [1]. The challenges of learning new clinical knowledge and skillsets are not unique to nephrology, and most training…
Source: Kidney MedicineCategories: Latest Headlines, NephrologyTweet-
RT @KidneyMed: Nephrology Fellow Boot Camp Training: A Single Center Experience https://t.co/zWFWEv0052 https://t.co/sphpzHtLlM
-
-
Mashup Score: 4
IgA nephropathy (IgAN) is one of the most common glomerular diseases worldwide and carries a high disease burden with 30%-40% of patients developing kidney failure.1 Given its heterogeneous course, a combination of clinical, laboratory, and histopathologic parameters are used to identify patients at risk of poor outcomes.2 Multiple trials have explored the use of corticosteroids and other…
Source: Kidney MedicineCategories: Latest Headlines, NephrologyTweet-
RT @KidneyMed: Steroids for IgA Nephropathy: A #NephJC Editorial on the TESTING trial @NephJC @NSMCInternship https://t.co/rvEzlqqqaK htā¦
-
-
Mashup Score: 3
Sodium-glucose cotransporter 2 (SGLT2) inhibitor have become widely used in patients with diabetes, heart failure, and kidney disease to improve clinical outcomes and diminish hospitalizations. They have also been associated with increased serum magnesium levels in patients with type 2 diabetes. The use of SGLT2 inhibitors resulted in improved magnesium homeostasis in a series of patients with…
Source: Kidney MedicineCategories: Cardiologists, Latest HeadlinesTweet-
Role of #SGLT2i in Management of Refractory #Hypomagnesemia Without Overt Urinary Magnesium Wasting: A Report of 2 Cases The pathophysiology of how #magnesium homeostasis is altered with #SGLT2i @KidneyMed @Nephro_Sparks https://t.co/A7WM45TLcq @scottdsolomon @JavedButler1 https://t.co/dOJkYW93Oq
-
-
Mashup Score: 4
Inaugural consensus statements were developed and endorsed by the American College of Radiology (ACR) and National Kidney Foundation to improve and standardize the care of patients with kidney disease who have indication(s) to receive ACR-designated group II or group III intravenous gadolinium-based contrast media (GBCM). The risk of nephrogenic systemic fibrosis (NSF) from group II GBCM in…
Source: Kidney MedicineCategories: Hem/Oncs, Latest HeadlinesTweet-
I recognize that the risk of NSF is extremely low with Group 2 and 3 gadolinium agents The consensus statement from ACR & NKF says that multiple day HD sessions are not necessary following Gd exposure in HD patients https://t.co/2Wu46drlJB https://t.co/ADY8rOgMvE
-
-
Mashup Score: 4
The proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor alirocumab is used in the general population to treat dyslipidemia, but little is known about the effects of alirocumab on lipid levels, biomarkers, the metabolome, and safety in individuals receiving maintenance dialysis.
Source: Kidney MedicineCategories: Cardiologists, Latest HeadlinesTweet-
#PCSK9i #Alirocumab in #ESRD https://t.co/FAdIohWLfU
-
-
Mashup Score: 0
With a growing number of medications and therapies available to treat chronic kidney disease (CKD), risk-versus-benefit discussions are increasingly critical. Balancing risks and benefits requires assessing patientsā understanding of these, as well as incorporating patient preferences and tolerance for side effects into shared decision making.
Source: Kidney MedicineCategories: Latest Headlines, NephrologyTweet-
Balancing risks and benefits requires assessing patientsā understanding of these, as well as incorporating patient preferences and tolerance for side effects into shared decision making. Read more on @KidneyMed https://t.co/bk1H6d53U3
-
RT @NephroP: Hepatic and portal vein #POCUS from lateral and subxiphoid windows. #VExUS #Nephpearls š https://t.co/u2cFIzkUgw https://t.coā¦